to remain fragile as overall purchasing power has not yet recovered, and household debt remains at a high level. The operating result of the Company in this quarter is still in line with the plan
of high-cost care. For high-cost care revenue, the Company recorded at lower rate from THB. 12,800 in Y2019 to THB 10,679 per score this year. The actual receipt from Social Security Office was at THB
follow; Consolidated 2Q/2017 2Q/2016 Change Financial Statements (Million Baht) (%) (Million Baht) (%) (%) Revenue from Sales 1,211.6 100.0 % 1,119.8 100.0 % 8.2 % Cost of Sales (827.0) (68.3 %) (725.6
the same period of last year and a decrease of 5.28% over the last quarter . Such decrease was mainly due to dropping in metal price and low level of production and sales. 2. Cost of sales was 384.25
, maintenance cost, and marketing expenses. However, the transportation and utility costs were in the rising trend. SG&A as a percentage of sales remained close to the same level at 19.72% compared to the
promising growth was attributed by the increase of number of patients as well as bill amount per patient. A yoy slight decline of social security revenue were mainly from high care cost revenue following the
for an increased level of production and the Company’s aggressive growth from 2018 onwards; 3) cost from trial runs and start-up of a new production line for some products, driving higher yield loss and
private consumption, especially on the cost of living in the low-to-middle income consumer group. The mobile competition landscape in 3Q22 persisted at the same level as the previous quarter across all
private consumption, especially on the cost of living in the low-to-middle income consumer group. The mobile competition landscape in 3Q22 persisted at the same level as the previous quarter across all
private consumption, especially on the cost of living in the low-to-middle income consumer group. The mobile competition landscape in 3Q22 persisted at the same level as the previous quarter across all